REG - Abbott Laboratories - Abbott Laboratories Rule 425 <Origin Href="QuoteRef">ABT.N</Origin>

Abbott LaboratoriesAnnouncement

06/09/2014 18:27

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140717:nRSQ6692Ma


RNS Number : 6692M
Abbott Laboratories
17 July 2014 
 
Notification to RNS 
 
Company:         Abbott Laboratories 
 
TIDM: ABT 
 
Headline:          Abbott Laboratories Files Rule 425 Documents 
 
Abbott Laboratories (the "Company") 
 
17 July 2014 
 
Abbott Laboratories Files Rule 425 Documents 
 
The Company informs its shareholders that on 16 July 2014, two documents were
filed with the U.S. Securities and Exchange Commission ("SEC") pursuant to
Rule 425 of the U.S. Securities Act of 1933, as amended ("Rule 425
Documents"). These Rule 425 Documents can be found on the SEC website at
http://www.sec.gov. 
 
Copies of the Rule 425 Documents have been submitted to the National Storage
Mechanism on the date of this announcement and are, or will shortly be,
available for inspection at http://www.morningstar.co.uk/uk/NSM. 
 
Issued by: Abbott Laboratories 
 
CONTACT:  Financial, Brian Yoor, +1-847-937-6343, or Tina Ventura,
+1-847-935-9390, or Media, Melissa Brotz, +1-847-935-3456, or Scott Stoffel,
+1-847-936-9502. 
 
This information is provided by RNS
The company news service from the London Stock Exchange